| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Jan 16, 2018 | Sale | $24.30 | 87,000 | 2,114,225 | 45,094 | Jan 18, 2018, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Jan 02, 2018 | Option Exercise | $20.07 | 46,000 | 923,060 | 78,204 | Jan 04, 2018, 07:14 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Dec 28, 2017 | Option Exercise | $18.09 | 1,400 | 25,326 | 115,904 | Jan 02, 2018, 04:18 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Dec 29, 2017 | Option Exercise | $19.58 | 45,600 | 892,964 | 124,274 | Jan 02, 2018, 04:18 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Dec 22, 2017 | Sale | $20.55 | 15,000 | 308,250 | 115,204 | Dec 27, 2017, 04:17 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Dec 15, 2017 | Sale | $18.90 | 15,000 | 283,496 | 130,204 | Dec 19, 2017, 04:10 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Aug 04, 2017 | Sale | $18.55 | 477 | 8,848 | 167,727 | Aug 08, 2017, 05:52 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Aug 07, 2017 | Sale | $18.56 | 13,210 | 245,209 | 154,517 | Aug 08, 2017, 05:52 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Aug 08, 2017 | Sale | $18.60 | 1,313 | 24,422 | 153,204 | Aug 08, 2017, 05:52 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | May 01, 2017 | Sale | $16.61 | 1,852 | 30,753 | 168,204 | May 03, 2017, 05:17 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 28, 2017 | Sale | $16.62 | 4,912 | 81,638 | 170,056 | Apr 28, 2017, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 26, 2017 | Sale | $16.76 | 3,200 | 53,641 | 180,495 | Apr 28, 2017, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 27, 2017 | Sale | $16.84 | 13,527 | 227,799 | 174,968 | Apr 28, 2017, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 21, 2017 | Sale | $17.02 | 3,010 | 51,222 | 192,017 | Apr 25, 2017, 07:37 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 24, 2017 | Sale | $16.44 | 3,522 | 57,897 | 188,495 | Apr 25, 2017, 07:37 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 25, 2017 | Sale | $16.87 | 4,800 | 80,990 | 183,695 | Apr 25, 2017, 07:37 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 20, 2017 | Sale | $17.37 | 2,937 | 51,025 | 195,027 | Apr 21, 2017, 04:31 PM | |
| CRSP | CRISPR Therapeutics AG | Dylan-Hyde Tyler | Chief Legal Officer | Apr 19, 2017 | Sale | $17.84 | 7,240 | 129,165 | 200,274 | Apr 21, 2017, 04:31 PM |
Menu